Read More

Mesoblast Completed A Global Private Placement Raising Approximately US$40M

Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, today announced it has completed a global private placement primarily to Mesoblast's existing major US, UK, and Australian shareholders raising approximately US$40 million, net of transaction costs, at A$0.85 per share.

MESO

Read More

Whole Earth Brands Announces Leadership Evolution with New Executive Appointments And Amends Credit Agreement; Bernardo Fiaux Named As Chief Financial Officer; Reaffirms Full Year 2023 Guidance

Branded CPG International Regions to be Operated Collectively Under New Leadership   Nigel Willerton, Founder of Wholesome Sweeteners, Named as President and COO of Branded CPG North America Region Rajnish Ohri,

FREE